Daily Trade News

Value-based Renal Care to Provide a Strong Platform for Payer-driven


Dublin, Sept. 29, 2021 (GLOBE NEWSWIRE) — The “Global Renal Care Management Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering.

The global prevalence of CKD is estimated to be about 9% to 10%

Chronic Kidney Disease (CKD) is associated with poor outcomes, mainly due to the high burden of comorbidity. Along with rising aging population, increasing number of CKD patients are suffering from comorbidities such as hypertension, diabetes, heart failure, cancer, and mental ill health.

Renal care management has been expanding from the stage of just caring for End Stage Renal Disease (ESKD) patients to prevention of patients from developing chronic kidney diseases. Statistics suggest that approximately 90% of the patients are not even aware that they have a kidney disease, and estimated 38% of ESKD patients eventually require dialysis.

Renal care solution providers understand the importance of managing associated comorbid conditions and are, therefore, offering collaborative solutions that target these conditions. Fresenius has collaborated with Livongo (part of Teladoc) to allow its CKD patients to access Livongo’s proven hypertension and diabetes management solutions.

Major participants such as Fresenius and Diaverum are already offering care coordination solutions and exploring the 360-care model for both patients undergoing treatment and the at-risk patient group.

Specialized technology companies such as Cricket Health and Somatus are offering an integrated care model to their partners based on their proprietary data-driven predictive technology.

The adoption of integrated, value-based model is expected to prevent or delay disease progression as well as improve care quality.

Key Topics Covered:

1. Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?

  • The Strategic Imperative

  • The Impact of the Top Three Strategic Imperatives on the Global Renal Care Management Market

  • Growth Opportunities Fuel the Growth Pipeline Engine

  • Growth Environment

  • Renal Care – Increasing Clinical Burden and Need for Care Innovation

  • Race to Renal Value Based Care (VBC)

  • VBC to Provide a Strong Platform for Payer-driven Innovations and Major Industry Disruptions

  • Patient-centric Approach to Provide Technology Innovation and New Care Model Opportunities

2. Growth Opportunity Analysis – Renal Care Management

  • Key Questions This Study Will Answer

  • Scope of Analysis

  • Market Segmentation

  • Renal Care – Increasing Clinical Burden and Need for Care Innovation

  • COVID-19 to Directly Impact the Demand for Renal Care Solutions

  • High Economical Burden for Kidney Failure

  • Dialysis Accessibility Impacted by Affordability, Supply Shortage, Government Polices, as well as Clinical Preference

  • Growth Drivers for Renal Care Management

  • Growth Restraints for Renal Care Management

3. Forecast Analysis – Dialysis Products Market

  • Forecast Assumptions – Dialysis Products Market

  • Key Growth Metrics for Global Dialysis Products Market

  • Revenue Forecast – Global Dialysis Products Market

  • Revenue…



Read More: Value-based Renal Care to Provide a Strong Platform for Payer-driven